Keywords: small, number, combination, drugs, reaching, japanese, market
Small number of combination drugs reaching the Japanese market
Article | 24 September 2007
The launch of combination drugs in Japan, such as Preminent (losartan/hydrochlorothiazide) from Banyu Pharmaceutical, the Japanese subsidiary of US ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
